Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


The abstract submission system is now open

Submit your abstract

Abstract submission deadlines


Date and time


12 July 2022, 18:00 SGT (local Singapore Time) / 12:00 CEST (Central European Summer Time)

Late breaking abstracts

Final submission deadline* 11 October 2022, 18:00 SGT (local Singapore time) / 12:00 CEST (Central European Summer Time)

Outcome notifications

Outcome notifications are expected to be made available to first authors by the end of September

Abstract submission categories

  • Breast cancer, early stage
  • Head and neck cancer, excluding thyroid
  • Breast cancer, locally advanced
  • Palliative care
  • Breast cancer, metastatic
  • Precision medicine
  • Developmental therapeutics
  • Supportive care
  • Gastrointestinal tumours, colorectal
  • Thoracic tumours, early stage
  • Gastrointestinal tumours, non-colorectal
  • Thoracic tumours, locally advanced
  • Genitourinary tumours, prostate
  • Thoracic tumours, metastatic
  • Genitourinary tumours, non-prostate
  • Miscellaneous
  • Gynaecological cancers
  • Young Oncologists patient case study
  • Haematological malignancies


Late-breaking abstracts

*A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline 12 July 2022.

The deadline for the submission of finalised late-breaking abstracts is 18:00 hrs SGT (local Singapore Time) / 12:00 CEST (Central European Summer Time) on 11 October 2022.

Trial in Progress abstracts

Trial in Progress abstracts (TiPs) in all phases of clinical research (phases I to III) may be submitted to ESMO Asia Congress 2022.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  • Background
  • Trial design


  • Recruitment must have already begun or have been completed by the abstract submission deadline of 12 July 2022.
  • Abstracts including results or preliminary data will be rejected.
  • Trial in Progress abstracts can be accepted for Poster presentation only.
  • Encore TiP abstracts will not be accepted.

Young Oncologist (YO) Patient case studies

Challenging clinical case studies in the new era of personalised medicine may be submitted by young oncologists under 40 years of age.

Presentation of accepted abstracts

Abstracts will be reviewed by the ESMO Asia Congress 2022 Scientific Committee and considered on the merits of the scientific and clinical rationale of the trial.

The ESMO Asia 2022 Scientific Committee selected abstracts for presentation during the Congress based on the following possibilities:

  • Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives. 
  • Mini Oral – Short presentation by the authors with comment and interactive audience discussion led by an invited expert. 
  • Poster – An important method for communicating details of scientific research, posters will be on display for the duration of the Congress.

All accepted abstracts are published in the ESMO Asia Congress 2022 Abstract Book, a supplement to Annals of Oncology, except YO Patient case study Posters.

Publication schedule for accepted abstracts

  1. All regular abstracts accepted for presentation at ESMO Asia Congress 2022 as Proffered Paper (suffix O), Mini Oral (suffix MO), Poster (suffix P or TiP) will be published online via the ESMO website at 00:05 SGT on Monday, 28 November 2022.
  2. All Late-breaking abstracts accepted for presentation at ESMO Asia Congress 2022 as Proffered Paper or Mini Oral (prefix LBA) will be published online via the ESMO website at 00:05 SGT on Thursday, 1 December 2022.
  3. Details regarding ESMO PR activities will be made available two weeks prior to the Congress.


Date and time

 Regular abstracts accepted as:

  • Proffered Paper (suffix ‘O’)
  • Mini Oral (suffix ‘MO’)
  • Poster (suffixes ‘P’ and ‘TiP’)
  • YO Poster (prefix ‘YO)

Monday, 28 November 2022
00:05 Singapore Time (SGT)


 All late-breaking abstracts (prefix ‘LBA’)

Thursday, 1 December 2022
00:05 Singapore Time (SGT)

 ESMO PR activities

 Details regarding ESMO PR activities will be made available two weeks prior to the Congress

Embargo Policy

Data and information included in accepted abstracts is under embargo until the relevant embargo release date cited in the schedule above.

Data and information beyond what is included in the accepted abstracts, e.g., full data sets, may only be made public at the start of the official programme session during which the study is presented.

ESMO Merit travel grant

A limited number of ESMO Merit travel grants to ESMO Asia Congress 2022 are available, upon application, to first authors (= presenter) who submit abstracts considered to be deserving of recognition. Candidates must be ESMO Members under the age of 40. Selection will be made by the ESMO Asia Congress 2022 Scientific Committee on a competitive basis from among the accepted abstracts.

The application for an ESMO Merit travel grant must be completed during the abstract submission process. Applicants will be required to reply to the following questions:

  • How relevant to your current practice are the topics presented at this Congress?
  • Have you attended any event on a similar topic in the last 3 years?
  • How will attendance at this Congress help with your professional development?
  • How can your abstract contribute to the topics covered at this Congress?
  • Have you recently been awarded an ESMO Award/Travel Grant? If yes, for which event?

And to provide the following documents:

  • A copy of the submitted abstract (NOTE: The applicant must be the first and presenting author)
  • A readable photocopy of either identity card or passport
  • A short curriculum vitae (max. 2 pages)

ESMO will provide the recipients with a subsidised travel ticket, subsidised accommodation and Congress registration.

Incomplete applications will not be considered.

ESMO Merit travel grant recipients must submit a report detailing the benefits of participating in ESMO Asia Congress 2022 by 17 December 2022.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.